INmune Bio Receives MHRA Written Alignment Supporting Planned 2026 UK Conditional Marketing Authorization Application for CORDStrom™ in RDEB
Go back to INmune Bio Receives MHRA Written Alignment Supporting Planned 2026 UK Conditional Marketing Authorization Application for CORDStrom™ in RDEB| (NASDAQ: INMB) | Delayed: 1.62 -0.1 (5.81%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.72 | 52 Week High | $ | |||
| Open | $1.69 | 52 Week Low | $ | |||
| Day High | $1.71 | P/E | N/A | |||
| Day Low | $1.61 | EPS | $ | |||
| Volume | 186,095 | |||||
| (NASDAQ: INMB) | Delayed: 1.62 -0.1 (5.81%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.72 | 52 Week High | $ | |||
| Open | $1.69 | 52 Week Low | $ | |||
| Day High | $1.71 | P/E | N/A | |||
| Day Low | $1.61 | EPS | $ | |||
| Volume | 186,095 | |||||

